Humacyte (HUMA) Non-Current Debt (2020 - 2025)

Humacyte (HUMA) has 6 years of Non-Current Debt data on file, last reported at $17.7 million in Q3 2025.

• Non-Current Debt for Q3 2025 came in at $17.7 million, down 71.55% year-over-year; the trailing twelve-month figure through Sep 2025 was $17.7 million (down 71.55% YoY), and the FY2024 annual result was $64.2 million, up 66.32% from the prior year.
• Non-Current Debt retreated to $17.7 million in Q3 2025 per HUMA's latest filing, from $66.4 million in the prior quarter.
• Over five years, Non-Current Debt peaked at $66.4 million in Q2 2025 and troughed at $14.0 million in Q3 2021.
• A 5-year average of $40.4 million and a median of $36.2 million in 2023 frame the typical range for Non-Current Debt.
• The sharpest annual moves came in 2021 and 2025: Non-Current Debt jumped 3228.59% in 2021, then sank 71.55% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $27.4 million in 2021, then dropped by 11.24% to $24.3 million in 2022, then jumped by 58.94% to $38.6 million in 2023, then jumped by 66.32% to $64.2 million in 2024, then tumbled by 72.47% to $17.7 million in 2025.
• Business Quant data shows HUMA's Non-Current Debt at $17.7 million in Q3 2025, $66.4 million in Q2 2025, and $64.7 million in Q1 2025.